If you have been losing weight on tirzepatide, whether Mounjaro for diabetes or Zepbound for weight loss, you may be wondering what happens if you stop. The answer is similar to semaglutide, but with a few important differences worth understanding.
Key takeaway: Stopping tirzepatide typically leads to significant weight regain. Trial data shows patients who switched to placebo regained about half their lost weight within a year, while those who continued treatment kept losing.
What Makes Tirzepatide Different
Tirzepatide is a dual-action medication. Unlike semaglutide, which activates only GLP-1 receptors, tirzepatide activates both GLP-1 and GIP receptors.
GIP stands for glucose-dependent insulinotropic polypeptide. This dual mechanism produces greater weight loss, up to 22.5 percent of body weight in clinical trials, and may offer additional metabolic benefits.
But the same fundamental principle applies. Obesity is a chronic disease, and stopping treatment typically leads to weight regain.
The SURMOUNT-4 Trial
The SURMOUNT-4 trial was designed specifically to answer what happens when tirzepatide is stopped. All participants received tirzepatide for 36 weeks and lost an average of 20.9 percent of their body weight.
They were then randomly assigned to either continue tirzepatide or switch to placebo for another 52 weeks
The results confirmed what researchers expected. Participants who continued tirzepatide kept their weight loss, and lost an additional 5.5 percent. Those who switched to placebo regained roughly half of the weight they had lost. The gap between the two groups was substantial, about 14 percentage points.
The Dosing Schedule
Tirzepatide is dosed the same way for both Mounjaro and Zepbound:

- Weeks 1 to 4: 2.5 mg once weekly, a tolerability dose not expected to produce significant weight loss
- Every 4 weeks after: the dose increases, 5 mg, then 7.5 mg, then 10 mg, then 12.5 mg, then 15 mg
- Maintenance: the dose that achieves your goals with tolerable side effects. FDA-approved maintenance doses are 5 mg, 10 mg, or 15 mg weekly
Can You Stay on a Lower Dose of Tirzepatide?
Yes. Some patients maintain excellent results at 5 to 10 mg weekly, especially alongside consistent lifestyle habits. The FDA-approved maintenance doses for Zepbound include 5 mg, 10 mg, and 15 mg, which gives your Everest eClinic provider flexibility to balance effectiveness with tolerability.
Modeling studies suggest that switching from weekly to every-other-week dosing can cut costs by 50 percent while retaining 70 to 95 percent of weight loss, depending on the dose. This is an emerging strategy that may become more common as long-term data accumulate.
Tirzepatide vs. Semaglutide: Weight Regain at a Glance
| Factor | Tirzepatide | Semaglutide |
| Receptor targets | GLP-1 and GIP | GLP-1 only |
| Average weight loss in trials | Up to 22.5% of body weight | Up to 15% of body weight |
| Weight regain after stopping | About half of lost weight over 52 weeks | Similar pattern, comparable percentage |
| Every-other-week dosing potential | Retains 70–95% of results at lower cost | Retains 70–95% of results at lower cost |
| FDA-approved maintenance doses | 5 mg, 10 mg, 15 mg | 2.4 mg standard, lower doses used off-label for maintenance |
Frequently Asked Questions
Most patients begin regaining weight. SURMOUNT-4 data shows patients who switched to placebo regained about half of their lost weight within a year.
Likely, at least in part, unless you continue medical support and maintain the lifestyle habits built during treatment.
Trial data shows an average regain of roughly half the weight lost, though individual results vary based on lifestyle and how treatment is tapered.
Yes. FDA-approved maintenance doses include 5 mg, 10 mg, and 15 mg weekly, and many patients maintain results at the lower end under provider guidance.
Tirzepatide produces greater average weight loss in trials due to its dual GLP-1 and GIP mechanism, but both carry a similar risk of weight regain if stopped without a plan.
The Same Rules Apply
Just like with semaglutide, the best strategy for maintaining your results on tirzepatide includes a few consistent habits:
- Working with your provider to find the lowest effective maintenance dose
- Building a strong exercise foundation, especially strength training, during treatment
- Eating adequate protein, around 1.2 to 1.5 g per kg of body weight daily, to preserve muscle mass
- Planning with your provider rather than stopping abruptly
The medication opens the door. Your lifestyle habits determine whether you walk through it and stay there.
Worried about tirzepatide weight regain or thinking about adjusting your dose? Talk to a provider about tirzepatide before making any changes
Sincerely,
Geeta Sharma,
DNP Endocrinology Nurse Practitioner
Everest Diabetes & Weight Loss
Connecticut: (203) 689-0558 Office Phone or Text
Texas: Call: 512-541-2126

This article is for informational purposes and does not replace individualized medical advice. Talk to your provider before starting or stopping any medication.




